Annals of Clinical Psychiatry

, Volume 12, Issue 1, pp 35–42

Hair Loss in Psychopharmacology

  • Yekaterina Mercke
  • Huaibao Sheng
  • Tehmina Khan
  • Steven Lippmann
Article

DOI: 10.1023/A:1009074926921

Cite this article as:
Mercke, Y., Sheng, H., Khan, T. et al. Ann Clin Psychiatry (2000) 12: 35. doi:10.1023/A:1009074926921
  • 180 Downloads

Abstract

Medication-induced alopecia is an occasional side effect of many psychopharmaceuticals. Most of the mood stabilizer and antidepressant drugs can lead to this condition. Some antipsychotic and antianxiety agents induce alopecia. Hair loss is also related to hypothyroidism, which can be induced by lithium and other agents. Alopecia might not be reported by some people, but physicians should be aware of this potential problem which may contribute to noncompliance. Lithium causes hair loss in 12–19% of long-term users. Valproic acid and/or divalproex precipitates alopecia in up to 12% of patients in a dose-dependent relationship. Incidences up to 28% are observed with high valproate concentration exposures. These pharmaceuticals also can change hair color and structure. The occurrence of carbamazepine-induced alopecia is at or below 6%. Hair loss is less common with other mood stabilizers. Tricyclic antidepressants, maprotilene, trazodone, and virtually all the new generation of antidepressants may on rare occasions lead to alopecia. The same applies to haloperidol, olanzepine, risperidone, clonazepam, and buspirone, but not to other neuroleptics, benzodiazepines, or barbiturates, selected antihistamines, and antiparkinsonians. Discontinuation of the medication or dose reduction almost always leads to complete hair regrowth. The therapeutic value of mineral supplements remains unclear.

alopecia hair loss lithium valproic acid/divalproex (valproate) carbamazepine psychopharmaceuticals 

Copyright information

© American Academy of Clinical Psychiatrists 2000

Authors and Affiliations

  • Yekaterina Mercke
    • 1
  • Huaibao Sheng
    • 1
  • Tehmina Khan
    • 1
  • Steven Lippmann
    • 1
  1. 1.Department of Psychiatry and Behavioral ScienceUniversity of Louisville School of MedicineLouisville

Personalised recommendations